Welcome to Blood Cancer United Newsroom
Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.
News
FDA Approves New Drug for Patients with Rare Blood Cancer (Myelofibrosis)
The Food and Drug Administration (FDA) recently approved a drug for the treatment of intermediate or high-risk primary or secondary myelofibrosis, the…
Professional Education Webcasts
It's Time To Understand CAR-T Therapy For B-Cell Lymphoma: Earlier Indications Coming To A Community Near You
Part 1 of 4 in a series on: The Evolving Role of CAR T-cell Therapy for R/R B-cell Lymphomas: Improving Access and Outcomes
Patient Education Webcasts
What is New in CAR T-Cell Therapy?
Research
Secura Bio Announces Final Patient Enrolled in PRIMO Study and Inclusion of COPIKTRA® (duvelisib) in NCCN Guidelines for PTCL
SUMMERLIN, Nev., Feb. 9, 2022 - Secura Bio, Inc. announced that it completed enrollment on February 1, 2022, in the PRIMO study. PRIMO is evaluating C…
Patient Education Webcasts
Abnormalities of the Immune System in Cancer Patients
News
The Leukemia & Lymphoma Society’s Newest Event Aims to Power Groundbreaking Research and Support for Cancer Patients
It’s no secret the COVID-19 pandemic compelled individuals and communities nationwide to tap into their inner creativity and survival skills to pivot …
Who We Are
COVID-19 VACCINES FAQ FOR PATIENTS AND CAREGIVERS
The Leukemia & Lymphoma Society (LLS) hears from blood cancer patients and caregivers each day about the profound effects of the pandemic on their can…
Patient Education Webcasts
Living And Growing As A Family After Cancer
News
New Poll: Americans Believe It’s Time to Protect Consumers From Predatory Short-Term Health Plans
An overwhelming majority of adults (79%) believes the government should regulate insurance products that exploit loopholes to discriminate against can…
Bridge Investment Group’s Jeff Shaw named Corporate Council Chair
The Leukemia & Lymphoma Society (LLS) Georgia - South Carolina Region is pleased to announce the appointment of Jeff Shaw, Partner of Bridge Investmen…
News
LLS Statement on COVID-19 Omicron Variant for Blood Cancer Patients and Survivors
Given the rapid rise in COVID-19 infections caused by the Omicron variant, The Leukemia & Lymphoma Society has developed this page to provide blood ca…
For all media-related inquiries and interview requests please email
mediarelations@bloodcancerunited.org
A Blood Cancer United representative will respond as soon as possible.
